The vascular access devices market in India is projected to grow at a compound annual growth rate (CAGR) of 6.81% from FY2026 to FY2033, increasing from USD 479.93 million in FY2025 to USD 761.07 million by FY2033. This upward trend is primarily driven by the growing incidence of lifestyle-related conditions such as diabetes and cancer, both of which often necessitate prolonged vascular access. Government investments in healthcare infrastructure, along with improved access to medical services, are further accelerating market growth. Technological advancements in catheter design and materials are also enhancing safety and efficiency, contributing to greater adoption across medical facilities.
Click – https://www.marketsandata.com/industry-reports/india-vascular-access-devices-market
Report Highlights:
- Base Year: FY2025
- Forecast Period: FY2026–FY2033
- Historical Period: FY2019–FY2024
- Expected Growth: 6.81% CAGR
- Forecasted Market Size (FY2033): USD 761.07 million
In a notable development, Abbott introduced a new vascular imaging system in India, powered by its Ultreon 1.0 software. This AI-driven platform, which utilizes optical coherence tomography (OCT), offers clinicians a detailed view of coronary artery blockages and blood flow. It automates key assessments like vessel diameter and plaque composition, and assists with precise stent placement, enhancing procedural outcomes in real time.
Rising Disease Burden and Healthcare Demands
India continues to see an increase in chronic and infectious diseases, such as cardiovascular conditions, chronic kidney disease, cancer, and infections like dengue and sepsis. These health issues often require repeated hospitalization and intravenous therapies, thereby increasing the demand for vascular access devices. The aging population, which is more vulnerable to such conditions, further contributes to this growing need. Additionally, national health initiatives like Ayushman Bharat are expanding access to care, leading to more procedures involving vascular access technologies.
Noncommunicable diseases (NCDs) now surpass infectious diseases in terms of mortality in India, with 5.8 million deaths annually attributed to NCDs. The WHO reports that in Southeast Asia, NCDs account for 62% of all deaths, highlighting the urgent need for effective long-term treatment infrastructure, including vascular access devices.
Infrastructure Growth and Technological Progress
India’s healthcare infrastructure is evolving rapidly, with growth in both public and private sectors. The adoption of modern medical technologies—including next-gen vascular access devices with extended dwell times and better infection prevention—is on the rise. Indian manufacturers like Poly Medicure and Newtech Medical Devices are producing high-quality, cost-effective solutions under the “Make in India” initiative. These innovations have made advanced devices more accessible across both Tier 1 and Tier 2 cities. For example, in August 2023, Poly Medicure launched its 10th manufacturing unit in India to expand its vascular access product line.
Hospitals are increasingly using imaging-guided tools, antimicrobial-coated catheters, and closed IV systems to enhance patient outcomes and minimize complications.
Growing Use of Central Vascular Access Devices (CVADs)
Demand for CVADs is climbing, particularly in ICUs and oncology departments. These devices are vital for delivering large volumes of fluids, chemotherapy, and nutrition over extended periods. PICCs, tunneled catheters, and implantable ports are favored for their durability and lower risk of infection. Rising cases of organ transplants, dialysis, and cancer are contributing to increased usage of CVADs. Institutions like AIIMS Delhi have recently upgraded their ICU equipment to include antimicrobial-coated central venous catheters, reflecting the growing emphasis on infection control and high-performance vascular devices in critical care.
Market Outlook: FY2026 – FY2033
The Indian vascular access devices market is poised for sustained growth, propelled by increasing healthcare needs, rising hospital admissions, and government efforts to strengthen both public and private medical infrastructure. As awareness around infection control improves and safer, more efficient intravenous access methods become standard, the demand for advanced vascular devices will continue to rise. Strengthened by local manufacturing and international partnerships, the industry is set to meet both domestic and global standards.
Latest reports-
https://www.marketsandata.com/industry-reports/united-states-golf-shoes-market
https://www.marketsandata.com/industry-reports/aircraft-component-market
Contact
Mr. Vivek Gupta
5741 Cleveland street,
Suite 120, VA beach, VA, USA 23462
Tel: +1 (757) 343–3258
Email: info@marketsandata.com
Website: https://www.marketsandata.com
Comments
0 comment